{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Jacksonville&page=17&state=Florida", "query": { "state": "Florida", "city": "Jacksonville", "page": 17 }, "page_size": 10 }, "pagination": { "page": 17, "page_size": 10, "total_count": 7623, "total_pages": 763, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Jacksonville&page=18&state=Florida&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Jacksonville&page=16&state=Florida&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-31T12:08:32.836Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03949673", "title": "Study to Evaluate Arthroplasty Specimens for Osteoarthritis of the Knee and Hip", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Osteoarthritis, Knee", "Osteoarthritis, Hip" ], "interventions": [ { "name": "Fasinumab", "type": "DRUG" }, { "name": "Naproxen", "type": "DRUG" }, { "name": "Diclofenac", "type": "DRUG" }, { "name": "Celecoxib", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Regeneron Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 23, "start_date": "2019-04-08", "completion_date": "2020-08-25", "has_results": true, "last_update_posted_date": "2023-10-17", "last_synced_at": "2026-10-31T12:08:32.836Z", "location_count": 6, "location_summary": "Phoenix, Arizona • Littleton, Colorado • Jacksonville, Florida + 3 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Littleton", "state": "Colorado" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Brooklyn", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03949673" }, { "nct_id": "NCT06846541", "title": "Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Plaque Psoriasis", "Psoriasis (PsO)", "Psoriasis", "Moderate Psoriasis", "Severe Psoriasis" ], "interventions": [ { "name": "Open-Label Envudeucitinib", "type": "DRUG" }, { "name": "Blinded Envudeucitinib", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alumis Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1680, "start_date": "2025-01-08", "completion_date": "2028-11", "has_results": false, "last_update_posted_date": "2026-04-13", "last_synced_at": "2026-10-31T12:08:32.836Z", "location_count": 92, "location_summary": "Birmingham, Alabama • Chandler, Arizona • Pheonix, Arizona + 79 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Pheonix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT06846541" }, { "nct_id": "NCT00641056", "title": "Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "Exenatide Once Weekly", "type": "DRUG" }, { "name": "Insulin Glargine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 467, "start_date": "2008-04", "completion_date": "2009-11", "has_results": true, "last_update_posted_date": "2015-06-15", "last_synced_at": "2026-10-31T12:08:32.836Z", "location_count": 12, "location_summary": "Escondido, California • Jacksonville, Florida • Orlando, Florida + 9 more", "locations": [ { "city": "Escondido", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "West Palm Beach", "state": "Florida" }, { "city": "Honolulu", "state": "Hawaii" } ], "official_url": "https://clinicaltrials.gov/study/NCT00641056" }, { "nct_id": "NCT04369729", "title": "Investigate the Mechanisms, Predictors, and Prevention of Persistent Post-Traumatic Headache", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Post-Traumatic Headache" ], "interventions": [], "intervention_types": [], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 101, "start_date": "2020-09-09", "completion_date": "2025-08-31", "has_results": false, "last_update_posted_date": "2025-09-12", "last_synced_at": "2026-10-31T12:08:32.836Z", "location_count": 5, "location_summary": "Phoenix, Arizona • Scottsdale, Arizona • Jacksonville, Florida + 1 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT04369729" }, { "nct_id": "NCT06388122", "title": "DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Breast Cancer Patients", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "HER2-negative Breast Cancer", "Hormone-receptor-positive Breast Cancer", "Metastatic Breast Cancer", "Anatomic Stage II Breast Cancer AJCC v8", "Anatomic Stage III Breast Cancer AJCC v8", "Anatomic Stage IV Breast Cancer AJCC v8", "HER2 Negative Breast Carcinoma", "Hormone Receptor Positive Breast Carcinoma", "Metastatic Breast Carcinoma" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 100, "start_date": "2024-04-30", "completion_date": "2031-06-15", "has_results": false, "last_update_posted_date": "2026-06-01", "last_synced_at": "2026-10-31T12:08:32.836Z", "location_count": 1, "location_summary": "Jacksonville, Florida", "locations": [ { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06388122" }, { "nct_id": "NCT01432353", "title": "A Study of DFRF4539A in Patients With Relapsed or Refractory Multiple Myeloma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Multiple Myeloma" ], "interventions": [ { "name": "DFRF4539A", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Genentech, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 39, "start_date": "2011-09", "completion_date": "2014-04", "has_results": false, "last_update_posted_date": "2016-11-02", "last_synced_at": "2026-10-31T12:08:32.836Z", "location_count": 8, "location_summary": "Scottsdale, Arizona • Duarte, California • Jacksonville, Florida + 5 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Duarte", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Sarasota", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT01432353" }, { "nct_id": "NCT01437995", "title": "Long-acting Beta Agonist Step Down Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fluticasone/Salmeterol Diskus", "type": "DRUG" }, { "name": "Fluticasone Diskus", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 459, "start_date": "2012-03", "completion_date": "2015-10", "has_results": true, "last_update_posted_date": "2017-04-25", "last_synced_at": "2026-10-31T12:08:32.836Z", "location_count": 19, "location_summary": "Tucson, Arizona • San Diego, California • Denver, Colorado + 15 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "San Diego", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01437995" }, { "nct_id": "NCT01426477", "title": "Veritas in Non-Bridging Ventral Hernia Repair", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Hernia" ], "interventions": [], "intervention_types": [], "sponsor": "Baxter Healthcare Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2011-08", "completion_date": "2017-08", "has_results": false, "last_update_posted_date": "2018-01-23", "last_synced_at": "2026-10-31T12:08:32.836Z", "location_count": 4, "location_summary": "Jacksonville, Florida • Lakeland, Florida • Atlanta, Georgia + 1 more", "locations": [ { "city": "Jacksonville", "state": "Florida" }, { "city": "Lakeland", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Fredericksburg", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01426477" }, { "nct_id": "NCT05580588", "title": "Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Liposarcoma, Dedifferentiated" ], "interventions": [ { "name": "SPH4336", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Shanghai Pharma Biotherapeutics USA Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 14, "start_date": "2023-08-31", "completion_date": "2024-10-31", "has_results": true, "last_update_posted_date": "2025-06-13", "last_synced_at": "2026-10-31T12:08:32.836Z", "location_count": 9, "location_summary": "Phoenix, Arizona • Duarte, California • Jacksonville, Florida + 6 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Duarte", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT05580588" }, { "nct_id": "NCT00698841", "title": "Study to Evaluate the Effect of Cetuximab on Corrected QT (QTc) Interval Changes in Patients With Advanced Malignancies From Solid Tumors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Advanced Cancer" ], "interventions": [ { "name": "Cetuximab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 79, "start_date": "2009-02", "completion_date": "2010-02", "has_results": true, "last_update_posted_date": "2015-12-24", "last_synced_at": "2026-10-31T12:08:32.836Z", "location_count": 15, "location_summary": "Muscle Shoals, Alabama • Casa Grande, Arizona • Corona, California + 12 more", "locations": [ { "city": "Muscle Shoals", "state": "Alabama" }, { "city": "Casa Grande", "state": "Arizona" }, { "city": "Corona", "state": "California" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00698841" } ] }